Abstract:Background: Abnormality in the concentraiton and funcitoning ofgamma-aminobutyric acid (γ-aminobutyric acid, GABA) in the brain is not only an important hypotheitcal link to the cause of schizophrenia but it may also be correlated with the cognitive decline and negative symptoms of schizophrenia. Studies utilizing high field magnetic resonance spectroscopy (MRS) report abnormal density of GABA in the ventromedial prefrontal cortex (vmPFC) of paitents with chronic schizophrenia, but these results may be confounded by study paritcipants’ prior use of anitpsychoitc medicaitons. Aim: Compare the density of GABA in the vmPFC of paitents with ifrst-episode psychosis to that in healthy controls and assess the relaitonship of GABA density in the vmPFC to the severity of psychoitc symptoms. Methods: Single-voxel1H-MRS was used to assess the concentraiton of GABA and other metabolites in the vmPFC of 22 patients with first-episode psychosis (10 with schizophrenia and 12 with schizophreniform disorder) and 23 healthy controls. Thirteen of the 22 paitents were drug-na?ve and 9 had used anitpsychoitc medicaiton for less than 3 days. The Posiitve and Negaitve Syndrome Scale (PANSS) was used to evaluate the severity of psychoitc symptoms in the paitent group. Results: The mean (sd) GABA density in the vmPFC was signiifcantly higher in paitents than in controls (2.28 [0.54]v. 1.93 [0.32]mM,t=2.62,p=0.012). The densiites of other metabolites – includingN-acetylasparitc acid (NAA), glutamic acid (GLU), and glutamine (GLN) – were not signiifcantly different between paitents and controls. Among the paitents, GABA density in the vmPFC was not signiifcantly correlated with PANSS total score or with any of the three PANSS subscale scores for posiitve symptoms, negaitve symptoms, and general psychopathology. GABA concentraiton was not associated with the duraiton of illness, but it was signiifcantly correlated with paitent age (r=0.47,p=0.026). Conclusions: Elevaiton of GABA density in the vmPFC of paitents with ifrst-episode psychosis conifrms that this abnormality is independent of medicaiton use. The failure to ifnd a correlaiton of GABA density in the vmPFC with the severity of psychoitc symptoms needs to be conifrmed in larger studies, but it suggests that there are several intervening steps between brain pathology and clinical symptoms.

GABAergic Abnormalities Associated with Sensorimotor Cortico-striatal Community Structural Deficits in ErbB4 Knockout Mice and First-Episode Treatment-Naïve Patients with Schizophrenia

F206. A TRANSLATIONAL STUDY OF BEHAVIOR, BRAIN STRUCTURE AND GENE PATHWAY IN ERBB4 KNOCKOUT MICE AND FIRST-EPISODE TREATMENT-NAïVE PATIENTS WITH SCHIZOPHRENIA

Altered brain activity in the bilateral frontal cortices and neural correlation with cognitive impairment in schizophrenia

Multiomics Analyses Reveal Microbiome–Gut–Brain Crosstalk Centered on Aberrant Gamma-Aminobutyric Acid and Tryptophan Metabolism in Drug-Naïve Patients with First-Episode Schizophrenia

Development of GABA Circuitry of Fast-Spiking Basket Interneurons in the Medial Prefrontal Cortex of Erbb4-Mutant Mice.

Depth‐dependent Abnormal Cortical Myelination in First‐episode Treatment‐naïve Schizophrenia

Structural Covariance of Depth-Dependent Intracortical Myelination in the Human Brain and Its Application to Drug-Naive Schizophrenia: a T1w/T2w MRI Study

Schizophrenia-Like Deficits and Impaired Glutamate/Gamma-aminobutyric acid Homeostasis in Zfp804a Conditional Knockout Mice

Immunohistochemical evaluation of the GABAergic neuronal system in the prefrontal cortex of a DISC1 knockout mouse model of schizophrenia

Erbb4 Deletion From Medium Spiny Neurons Of The Nucleus Accumbens Core Induces Schizophrenia-Like Behaviors Via Elevated Gabaa Receptor Alpha 1 Subunit Expression

Unraveling the Prefrontal Cortex-Basolateral Amygdala Pathway's Role on Schizophrenia's Cognitive Impairments: A Multimodal Study in Patients and Mouse Models.

Neuropsychiatric Phenotypes Produced by GABA Reduction in Mouse Cortex and Hippocampus

erbb4 Deficits in Chandelier Cells of the Medial Prefrontal Cortex Confer Cognitive Dysfunctions: Implications for Schizophrenia.

GABAergic neuron dysregulation in a human neurodevelopmental model for major psychiatric disorders

Comparison of the Density of Gamma-Aminobutyric Acid in the Ventromedial Prefrontal Cortex of Patients with First-Episode Psychosis and Healthy Controls.

Correlation study of brain-derived neurotrophic factor, EEG γ activity and cognitive function in first-episode schizophrenia

Comparison of the density ofgamma-aminobutyric acid in the ventromedial prefrontal cortex of paitents with ifrst-episode psychosis and healthy controls

Aberrant Cortical Surface and Cognition Function in Drug-Naive First-Episode Schizophrenia

Aberrant neuronal connectivity and network activity of neurons derived from patients with idiopathic schizophrenia

Prolonged Cortical Silent Period among Drug-Naive Subjects at Ultra-High Risk of Psychosis.

Expressions of Neuregulin 1βand ErbB4 in Prefrontal Cortex and Hippocampus of a Rat Schizophrenia Model Induced by Chronic MK-801 Administration